Thomas Andrew Rowland

SVP, Head - Established Brands, ANI Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$0.4M

Companies

Latest trade

May 12, 2026

Companies

ANI PharmaceuticalsSVP, Head - Established Brands −$0.4M

Trades

ANIP Sold 459 shares at $79.21 $0.0M May 12

ANIP Sold 4,772 shares at $74.91 $0.4M Mar 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.